EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy

Keisuke Mori iD, Fumitoshi Kodaka iD, Arisa Yamamoto, Ryuichi Yamazaki, Junpei Ishii iD, Wataru Yamadera, Hisatsugu Miyata, Masahiro Shigeta

Neuropsychopharmacology Reports · 2024

DOI: 10.1002/npr2.12379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Keisuke Mori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Anti-Anxiety Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pharmacotherapy such as selective serotonin reuptake inhibitors (SSRIs) or serotonin‐noradrenaline reuptake inhibitors is recommended for the treatment of anxiety disorders. Although there are patients with persisted symptoms of anxiety disorders who are treated with monotherapy of benzodiazepine anxiolytics without SSRIs, the characteristics of these patients are unclear. In the present study, we investigated the characteristics of patients with persisted symptoms of anxiety disorder without SSRI prescription.

Methods

From a prescription dataset covering 2018 and 2020, the prescriptions of 243 patients with anxiety disorder were analyzed. Patients were classified into two groups: SSRI non‐prescription and prescription groups.

Results

The SSRI non‐prescription group had a higher ratio of females than did the SSRI prescription group (60.1% vs. 44.6%, respectively, p = 3.12 × 10 −2 ), but statistically not significant after the Bonferroni correction. No significant differences in age, body mass index, or duration of outpatient visits were found between groups. Among the independent variables, sex (female) was the only variable identified that predicted SSRI non‐prescription.

Conclusion

The present study showed that among patients with anxiety disorders, sex (female) was the only variable that predicted SSRI non‐prescription.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Selective Serotonin Reuptake InhibitorsAnti-Anxiety AgentsHumansFemaleAnxiety DisordersBenzodiazepinesPrescriptions

Stichwörter der Autor:innen

SSRIanxiety disorderanxiolyticsbenzodiazepinesprescription

Substanzen

Selective Serotonin Reuptake InhibitorsAnti-Anxiety AgentsBenzodiazepines

Autor:innen und Institutionen

  • Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Psychiatry, Jikei University Katsushika Medical Center, Tokyo, Japan.

ORCID-Profile: Keisuke Mori, Fumitoshi Kodaka, Junpei Ishii

Zitieren

APA

Mori, K., Kodaka, F., Yamamoto, A., Yamazaki, R., Ishii, J., Yamadera, W., Miyata, H., & Shigeta, M. (2024). Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12379

Vancouver

Mori K, Kodaka F, Yamamoto A, Yamazaki R, Ishii J, Yamadera W, et al. Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12379

BibTeX
@article{Mori2024,
  author = {Mori, Keisuke and Kodaka, Fumitoshi and Yamamoto, Arisa and Yamazaki, Ryuichi and Ishii, Junpei and Yamadera, Wataru and Miyata, Hisatsugu and Shigeta, Masahiro},
  title = {Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy},
  journal = {Neuropsychopharmacology Reports},
  year = {2024},
  doi = {10.1002/npr2.12379}
}
Kostenlos starten →